Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalMarket Capitalization

Mainz Biomed N.V (MYNZ) Return on Sales: 2022-2023

Historic Return on Sales for Mainz Biomed N.V (MYNZ) over the last 1 years, with Dec 2023 value amounting to -29.36%.

  • Mainz Biomed N.V's Return on Sales rose 2043.00% to -29.36% in Q4 2023 from the same period last year, while for Dec 2023 it was -29.36%, marking a year-over-year increase of 2043.00%. This contributed to the annual value of -24.22% for FY2024, which is 515.00% up from last year.
  • Mainz Biomed N.V's Return on Sales amounted to -29.36% in Q4 2023, which was up 12.41% from -33.53% recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed N.V's Return on Sales peaked at -29.36% during Q4 2023, and registered a low of -49.80% during Q4 2022.
  • Its 2-year average for Return on Sales is -37.82%, with a median of -36.24% in 2023.
  • Data for Mainz Biomed N.V's Return on Sales shows a peak YoY surged of 2,043bps (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Mainz Biomed N.V's Return on Sales stood at -49.80% in 2022, then skyrocketed by 2,043bps to -29.36% in 2023.
  • Its Return on Sales was -29.36% in Q4 2023, compared to -33.53% in Q3 2023 and -36.24% in Q2 2023.